Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
# Robots.txt file for www.alkermes.com User-agent: * Allow: / Sitemap: https://www.alkermes.com/sitemap.xml Host: |
Title | Alkermes – A Global Biopharmaceutical |
Description | Great ScienceDeep CompassionReal Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and |
Keywords | Lybalvi, Alks 1140, Neuroscience, LYBALVI™ (olanzapine and samidorphan), Schizophrenia, Bipolar I Disorder, Neurology, Orphan, Oncology, Nemvaleukin alfa |
WebSite | alkermes.com |
Host IP | 72.32.33.202 |
Location | United States |
Site | Rank |
US$91,660,415
Last updated: 2023-04-28 09:07:45
alkermes.com has Semrush global rank of 115,473. alkermes.com has an estimated worth of US$ 91,660,415, based on its estimated Ads revenue. alkermes.com receives approximately 10,576,202 unique visitors each day. Its web server is located in United States, with IP address 72.32.33.202. According to SiteAdvisor, alkermes.com is safe to visit. |
Purchase/Sale Value | US$91,660,415 |
Daily Ads Revenue | US$84,610 |
Monthly Ads Revenue | US$2,538,289 |
Yearly Ads Revenue | US$30,459,461 |
Daily Unique Visitors | 705,081 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
alkermes.com. | A | 3600 | IP: 72.32.33.202 |
alkermes.com. | NS | 7200 | NS Record: ns59.worldnic.com. |
alkermes.com. | NS | 7200 | NS Record: ns60.worldnic.com. |
alkermes.com. | MX | 7200 | MX Record: 10 mxb-00049901.gslb.pphosted.com. |
alkermes.com. | MX | 7200 | MX Record: 10 mxa-00049901.gslb.pphosted.com. |
alkermes.com. | TXT | 7200 | TXT Record: tP5HlxzA3cZ7PhwgbDp9JODgMzgfcobInlMx7of1YLyAyB8hGj1pAdc+jWTASRvgwC9TiCs3bQOmclEvAlrE6w== |
alkermes.com. | TXT | 7200 | TXT Record: x6cmy358b1glm4jvxly2x47g4wtmd85h |
alkermes.com. | TXT | 7200 | TXT Record: google-site-verification=TEWHAazwrUS8MJPuwmCyH1DW13xv3KsT4S1sfMa2i-8 |
alkermes.com. | TXT | 7200 | TXT Record: cisco-ci-domain-verification=1bbcda3ede409f09d8637bc63f3b4d10e2565eeb8c10bad0b990db1029041e55 |
alkermes.com. | TXT | 7200 | TXT Record: v=spf1 ip4:155.212.24.4 include:spf-00049901.pphosted.com include:mailgun.org include:spf.agiloft.com ~all |
alkermes.com. | TXT | 7200 | TXT Record: docusign=c5b9c7d2-6a95-430a-84e2-8ed1787ff829 |
alkermes.com. | TXT | 7200 | TXT Record: cisco-ci-domain-verification=77663e1b2eb99e3804cf794027f73b6b56ece73eb1d3b9535de870d4b9071469 |
alkermes.com. | TXT | 3600 | TXT Record: google-site-verification=VIKoKH0LC7hgUMhA5QQgFLET_uVkv8yUPvCG0u6hNOY |
alkermes.com. | TXT | 7200 | TXT Record: webexdomainverification.4C675B8BB1ADB136E053AB06FC0A3F65=b9cc6e58-4374-4932-bfe9-45379b041e7e |
alkermes.com. | TXT | 3600 | TXT Record: MS=ms79269034 |
alkermes.com. | TXT | 7200 | TXT Record: docusign=ceb9cdce-be3e-4b8a-8841-ac68176405f8 |
About Us Discover Alkermes Our Values Leadership Diversity, Inclusion & Belonging Collaborations Locations Medicines & Focus Our Focus Disease Areas Innovative Medicines Third-Party Medicines Research & Development Pipeline Scientific Platforms Technologies & Capabilities Research & Medical Grants Clinical Trials Early Access Responsibility Corporate Responsibility Patient Engagement & Advocacy Alkermes Inspiration Grants ® Corporate Giving Corporate Responsibility Reports Public Policy Investors Press Releases Investor Events / Presentations SEC Filings Annual Reports Corporate Governance Stock Information Investor Resources Email Alerts News & Events Press Releases Our Stories Media Resources Statements Contact Us Careers Working Here Our Culture Benefits Join Our Team Great Science Deep Compassion Real Impact Working together to address addiction, serious mental illness and cancer. Discover Alkermes Featured News April 26, 2023 Alkermes plc Reports First Quarter 2023 Financial |
HTTP/1.1 303 See Other Content-Length: 144 Content-Type: text/html; charset=UTF-8 Location: https://alkermes.com/ Server: Microsoft-IIS/10.0 X-Powered-By: ASP.NET Content-Security-Policy: frame-ancestors https://admin.alkermes.com https://www.alkermes.com X-XSS-Protection: 1; mode=block X-Content-Type-Options: nosniff Date: Thu, 21 Oct 2021 11:55:13 GMT HTTP/2 301 content-length: 148 content-type: text/html; charset=UTF-8 location: https://www.alkermes.com/ server: Microsoft-IIS/10.0 x-powered-by: ASP.NET content-security-policy: frame-ancestors https://admin.alkermes.com https://www.alkermes.com x-xss-protection: 1; mode=block x-content-type-options: nosniff date: Thu, 21 Oct 2021 11:55:12 GMT HTTP/2 200 cache-control: no-cache pragma: no-cache content-length: 28180 content-type: text/html; charset=utf-8 expires: -1 server: Microsoft-IIS/10.0 x-aspnetmvc-version: 5.2 x-aspnet-version: 4.0.30319 x-powered-by: ASP.NET content-security-policy: frame-ancestors https://admin.alkermes.com https://www.alkermes.com x-xss-protection: 1; mode=block x-content-type-options: nosniff date: Thu, 21 Oct 2021 11:55:13 GMT |
Domain Name: ALKERMES.COM Registry Domain ID: 5361793_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.networksolutions.com Registrar URL: http://networksolutions.com Updated Date: 2020-10-02T05:06:58Z Creation Date: 1995-10-03T04:00:00Z Registry Expiry Date: 2030-10-02T04:00:00Z Registrar: Network Solutions, LLC Registrar IANA ID: 2 Registrar Abuse Contact Email: abuse@web.com Registrar Abuse Contact Phone: +1.8003337680 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS59.WORLDNIC.COM Name Server: NS60.WORLDNIC.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-10T05:37:17Z <<< |